Russell Investments Group Ltd. Reduces Stake in TELA Bio Inc. by 27.3%
In a recent filing with the Securities & Exchange Commission, Russell Investments Group Ltd. has disclosed a 27.3% reduction in ...
Tag: TELA
TELA Bio: Prioritizing Anatomical Preservation and Restoration in Soft-Tissue Reconstruction Solutions
On May 11th, investors eagerly awaited the much-anticipated earnings report from TELA Bio (NASDAQ:TELA), a medical technology company that focuses ...
Major Shareholder Sells Shares in TELA Bio, Inc.
On Friday, April 21st, Orbimed Advisors LLC, a major shareholder in TELA Bio, Inc. (NASDAQ: TELA), sold 27,700 shares of ...
TELA Bios Public Offering Causes Drop in Stock Price
On April 19, 2023, TELA Bio (NASDAQ: TELA) made an announcement that caused a drop in its share price. The ...
TELA Bio Reveals Pricing of Underwritten Public Offering of Common Stock
TELA Bio, a leading medical technology firm, recently revealed the pricing of its underwritten public offering of 4.75 million common ...
TELA Bio Announces Public Offering of Common Stock
On April 18, 2023, TELA Bio - a leading medical technology company - revealed its intention to launch a public ...
Calamos Advisors LLC Decreases Position in TELA Bio, Inc.: Implications for Company’s Future
On April 9, 2023, it was reported that Calamos Advisors LLC had decreased its position in TELA Bio, Inc. by ...
TELA Bio Reports Mixed Q4 2021 Results
TELA Bio (NASDAQ: TELA) has recently announced its Q4 2021 financial results, which have garnered mixed reactions from the market. ...